ADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell® from Human Islets to Stem Cell-Derived Islets

About this update from Adocia Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3539,"height":1431,"url":"https://media.zenfs.com/en/business-wire.com/8bd33ff367982b0f7e2ff3bee85dfe89"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xNSRvepybJfSdCh2f4omVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM4ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8bd33ff367982b0f7e2ff3bee85dfe89","width":960,"height":388},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/D02cQj4ZtB16pTBXTXv2LQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD05NzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/8bd33ff367982b0f7e2ff3bee85dfe89","width":1200,"height":485}},"lazy":false},{"type":"text","content":"Main results are:","length":17,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"successful scale up from animal to human device for First-In-Human study","length":72,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"in vitro and in vivo maturation after encapsulation of immature stem cell-derived islets in AdoShell®","length":101,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"sustained long-term in vivo function and efficacy of stem cell-derived islets encapsulated in AdoShell®","length":103,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":276,"olType":false},{"type":"text","content":"LYON, France, June 24, 2025--(BUSINESS WIRE)--Regulatory News:","length":62,"tagName":"p"},{"type":"text","content":"Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity (the "Company"), today announced the presentation of the latest preclinical data from its innovative AdoShell® technology platform at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell® from Human Islets to Stem Cell-Derived Islets.","length":492,"tagName":"p"},{"type":"text","content":"AdoShell® is designed to implant human pancreatic islets from deceased donors or stem cell-derived islets cell to cure type 1 diabetes without immunosuppression.","length":161,"tagName":"p"},{"type":"text","content":"Adocia preclinical data presented at the International Pancreas and Is...

More updates from Adocia Sa